ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
OSE Immunotherapeutics Expands Collaboration with MAbSilico americanpharmaceuticalreview
February 05, 2021OSE Immunotherapeutics announced a new collaboration agreement with MAbSilico, a deep technology TechBio located in Tours, France, to use artificial intelligence (AI)-based software for therapeutic monoclonal antibody drug development.
Pharma Sources Insight July 2025
